1-3 of 3
Toshio Fukuda
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Impact of Antithrombin Deficiency on Efficacies of DU-176b, a Novel Orally Active Direct Factor Xa Inhibitor, and Antithrombin Dependent Anticoagulants, Fondaparinux and Heparin.

Toshio Fukuda, Yuko Honda, Chikako Matsumoto, Nobutoshi Sugiyama, PhD, Tadashi Matsushita, PhD, Masamitsu Yanada, PhD, Yoshiyuki Morishima, PhD, Toshiro Shibano, PhD
Journal: Blood
Blood (2005) 106 (11): 1874.
https://doi.org/10.1182/blood.V106.11.1874.1874
Published: 2005
Journal Articles

A Thrombin Inhibitor, but Not a Factor Xa Inhibitor, DU-176b, Aggravates Tissue Factor-Induced Hypercoagulation in Rats.

Yoshiyuki Morishima, PhD, Toshio Fukuda, Naoki Tsuji, PhD, Yuko Honda, Chikako Matsumoto, Taketoshi Furugohri, Toshiro Shibano, PhD
Journal: Blood
Blood (2005) 106 (11): 1878.
https://doi.org/10.1182/blood.V106.11.1878.1878
Published: 2005
Journal Articles

Antithrombotic Properties of DU-176b, a Novel, Potent and Orally Active Direct Factor Xa Inhibitor in Rat Models of Arterial and Venous Thrombosis: Comparison with Fondaparinux, an Antithrombin Dependent Factor Xa Inhibitor.

Toshio Fukuda, Chikako Matsumoto, Yuko Honda, Nobutoshi Sugiyama, PhD, Yoshiyuki Morishima, PhD, Toshiro Shibano, PhD
Journal: Blood
Blood (2004) 104 (11): 1852.
https://doi.org/10.1182/blood.V104.11.1852.1852
Published: 2004